SG11201403953QA - SOLUBLE IMMUNOREACTIVE <i>TREPONEMA PALLIDUM</i> TPN47 ANTIGENS - Google Patents

SOLUBLE IMMUNOREACTIVE <i>TREPONEMA PALLIDUM</i> TPN47 ANTIGENS

Info

Publication number
SG11201403953QA
SG11201403953QA SG11201403953QA SG11201403953QA SG11201403953QA SG 11201403953Q A SG11201403953Q A SG 11201403953QA SG 11201403953Q A SG11201403953Q A SG 11201403953QA SG 11201403953Q A SG11201403953Q A SG 11201403953QA SG 11201403953Q A SG11201403953Q A SG 11201403953QA
Authority
SG
Singapore
Prior art keywords
treponema pallidum
immunoreactive
soluble
tpn47 antigens
tpn47
Prior art date
Application number
SG11201403953QA
Inventor
Elke Faatz
Peter Schaarschmidt
Urban Schmitt
Christian Scholz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG11201403953QA publication Critical patent/SG11201403953QA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11201403953QA 2012-01-19 2013-01-16 SOLUBLE IMMUNOREACTIVE <i>TREPONEMA PALLIDUM</i> TPN47 ANTIGENS SG11201403953QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12000310.8A EP2617731A1 (en) 2012-01-19 2012-01-19 Soluble immunoreactive Treponema pallidum TpN47 antigens
PCT/EP2013/000108 WO2013107633A1 (en) 2012-01-19 2013-01-16 Soluble immunoreactive treponema pallidum tpn47 antigens

Publications (1)

Publication Number Publication Date
SG11201403953QA true SG11201403953QA (en) 2014-08-28

Family

ID=47749743

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201403953QA SG11201403953QA (en) 2012-01-19 2013-01-16 SOLUBLE IMMUNOREACTIVE <i>TREPONEMA PALLIDUM</i> TPN47 ANTIGENS

Country Status (13)

Country Link
US (1) US9316642B2 (en)
EP (2) EP2617731A1 (en)
JP (1) JP5985657B2 (en)
KR (1) KR101645113B1 (en)
CN (1) CN104080801B (en)
AU (1) AU2013211242B2 (en)
BR (1) BR112014017802B1 (en)
CA (1) CA2856187C (en)
ES (1) ES2561462T3 (en)
HK (1) HK1202126A1 (en)
MX (1) MX353464B (en)
SG (1) SG11201403953QA (en)
WO (1) WO2013107633A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109154616B (en) 2016-05-31 2022-07-12 豪夫迈·罗氏有限公司 Method for serological detection of viral antigens
CN109154617B (en) 2016-05-31 2022-08-26 豪夫迈·罗氏有限公司 Pretreatment method for rapid detection of HCV core antigen
WO2018141768A1 (en) 2017-02-02 2018-08-09 Roche Diagnostics Gmbh Immunoassay using at least two pegylated analyte-specific binding agents
CN110996986A (en) 2017-07-27 2020-04-10 豪夫迈·罗氏有限公司 Multi-epitope fusion protein of HCV antigen and application thereof
CN107385069A (en) * 2017-08-17 2017-11-24 北京出入境检验检疫局检验检疫技术中心 A kind of LAMP primer group, kit and method for being used to detect microspironema pallidum
CN110981947B (en) * 2019-12-16 2021-10-08 四川安可瑞新材料技术有限公司 Preparation and application of treponema pallidum TP47 recombinant antigen
CN111116718A (en) * 2020-02-17 2020-05-08 北京博生福生物技术有限责任公司 Protein connecting peptide and application thereof in modification of TP recombinant antigen
CN111530439B (en) * 2020-05-13 2023-12-19 郑州伊美诺生物技术有限公司 Method for preparing fixed-value syphilis specific antibody in serum

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681934A (en) * 1986-09-30 1997-10-28 Board Of Regents, The University Of Texas System 47-kilodalton antigen of Treponema pallidum
CA2193870C (en) * 1995-12-25 2000-07-18 Nobuyuki Ise Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen
WO1998013496A1 (en) 1996-09-26 1998-04-02 Medical Research Council Chaperone fragments
JPH1114627A (en) * 1997-06-24 1999-01-22 Sekisui Chem Co Ltd Immunological diagnosis reagent
JPH11287804A (en) * 1998-04-01 1999-10-19 Sekisui Chem Co Ltd Formation for immunoassay reagent, immunoassay reagent and immunoassay method
ATE522603T1 (en) 2001-06-22 2011-09-15 Hoffmann La Roche SOLUBLE COMPLEX CONTAINING RETROVIRAL SURFACE GLYCOPROTEINS AND FKPA OR SLYD
CN101293919B (en) * 2008-01-22 2011-08-17 中国人民解放军第三军医大学 Syphilis spirochete membrane antigen with shortened expression and uses thereof
EP2127678A1 (en) * 2008-05-26 2009-12-02 Roche Diagnostics GmbH SlpA as a tool for recombinant protein and enzyme technology
KR101101880B1 (en) 2008-11-25 2012-01-05 문우철 DNA chip, Kit for Detecting or Genotyping Bacteria Causing Sexually Transmitted Diseases, Genotyping antibacterial drug resistance and Detecting or Genotyping Method Using The Same
KR102041119B1 (en) * 2010-03-31 2019-11-06 세키스이 메디칼 가부시키가이샤 Reagent for assaying anti-treponema pallidum antibody

Also Published As

Publication number Publication date
JP5985657B2 (en) 2016-09-06
AU2013211242B2 (en) 2015-09-10
KR20140108730A (en) 2014-09-12
CA2856187A1 (en) 2013-07-25
WO2013107633A1 (en) 2013-07-25
EP2617731A1 (en) 2013-07-24
EP2804874B1 (en) 2015-12-02
CN104080801A (en) 2014-10-01
HK1202126A1 (en) 2015-09-18
BR112014017802B1 (en) 2022-06-14
US20150079604A1 (en) 2015-03-19
CN104080801B (en) 2018-04-03
KR101645113B1 (en) 2016-08-02
EP2804874A1 (en) 2014-11-26
CA2856187C (en) 2016-07-12
BR112014017802A2 (en) 2018-06-26
AU2013211242A1 (en) 2014-08-21
MX353464B (en) 2018-01-15
MX2014008293A (en) 2014-08-22
ES2561462T3 (en) 2016-02-26
US9316642B2 (en) 2016-04-19
JP2015506364A (en) 2015-03-02

Similar Documents

Publication Publication Date Title
IL293362B1 (en) Broadly-neutralizing anti-hiv antibodies
IL276234B (en) Antibody formulations
IL271697A (en) Anti-cxcr3 antibodies
IL223366B (en) Anti-cmet antibody
IL230719A0 (en) Highly galactosylated antibodies
SG11201403953QA (en) SOLUBLE IMMUNOREACTIVE &lt;i&gt;TREPONEMA PALLIDUM&lt;/i&gt; TPN47 ANTIGENS
EP2663642A4 (en) Treponema pallidum triplet antigen
ZA201408213B (en) Anti-transglutaminase 2 antibodies
AU2012904582A0 (en) Paddle